To understand the mechanism of action of the T-RECS-targeting ASO treatment and how T-RECS may regulate the growth and survival of NRAS-mutated/MAPK-pathway driven melanoma tumor cells, we profiled the activity of kinase enzymes in melanoma samples. Here, NRAS is linked to neoplasm.